There were 1,892 press releases posted in the last 24 hours and 429,987 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image